FDA Investigator Dr. Carmelo Rosa

Dr. Carmelo Rosa has inspections in 17 countries as of 23 Oct 2023. Dr. Carmelo Rosa has collaborated with a combinined 3662 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
51
Last Inspection Date:
23 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United Kingdom of Great Britain and Northern Ireland, Italy, Spain, Germany, Puerto Rico, United States of America, Sweden, Israel, Brazil, Japan, Belgium, Denmark, India, France, Uruguay, Ireland, Argentina
Co-Investigator(s):
Aditi S Thakur, Agnes M Santori, Alan A Rivera, Alicia M Mozzachio, Allison A Aldridge, PhD, Anastasia M Shields, Angelica M Hernandez, Anissa M Vargas, Ariel Cruz Figueroa, Arlene M Badillo, Azza Talaat, Babatunde D Babalola, Bo Chi, PhD, Bonita S Chester, Brenda Rivera, Brian R Yaun, Brooke K Higgins, Bryan L Mcguckin, Carl A Anderson, Carlos A Medina, CDR Ileana Barreto Pettit, CDR Rochelle B Young, RPh, MSA, Chaoying C Ma, Charisse K Green, Chelsea N Sealey, Christopher R Czajka, Christopher T Peters, Colleen F Hoyt, Cynthia J Lee, MS, Daniel J Lahar, Darren S Brown, Demitria J Xiradakis, Dennis Cantellops Paite, Deyaa Shaheen, Dipesh K Shah, Don H Bark, PhD, Dr. Jason R Caballero, Dr. Robert C Horan, MD, Edmund F Mrak, Jr, Elizabeth Ll Edwards, Emest F Bizjak, Frederick L Fricke, Gavin T Cua, Gayle S Lawson, George T Allen, Jr, German Rivera, Hector A Carrero, Hector J Colon Torres, Heriberto Negron Rivera, Ileana Pettit, Iraida Ortiz, Ivis L Negron, Ivis Lnegron Torres, Jacob G Lutz, Jaime E Pares, James A Lane, James C Maclaughlin, James D Planchon, James L Dunnie, Jr, James Norman, Jennifer D Hollstrom, Jennifer Lalama, Jennifer M Gogley, Joe X Phillips, Jolanna A Norton, Jorge E Martinez, Jorge L Gonzalez, Jorge L Guadalupe, Jorge L Lajara, Jose A Lopez, Jose A Moreno, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose E Melendez, DDC, Jose F Pedro, Jose Fpedrode Jesus, Jose M Cayuela, Jose R Hernandez, Jose R Lopez, Jose Velez, Junho Pak, Karen E D'orazio, Karen Takahashi, Karl D Hezel, Katherine E Jacobitz, Kenneth H Williams, Kham Phommachanh, Kim Lthomas Cruse, Laiza V Garcia, Lata C Mathew, PhD, Laurel A Beer, Lauren N Howard, Lauren N Smith, LCDR Chad N Thompson, Libia M Lugo, Linda L Ng, Lisa Hornback, Lisa M Bellows, Lisa M Lopez, Lisa R Hilliar, Lori J Silverstein, Lourdes Andujar, LT Rafael Gonzalez, Lucas B Leake, Luis Soto Lopez, Maan S Abduldayem, Makini Cobourne Duval, PhD, Margaret M Annes, Margarita Santiago, Marian E Ramirez, Marianela Aponte, Marianela Aponte Cruz, Maribel V Juarbe, Marie T Falcone, Marilyn Santiago, Marta E Gonzalez, Mary E Farbman, PhD, Massoud Motamed, Matthew R Dionne, Megan A Haggerty, Meisha R Sampson, Meisha Waters, Michael A Charles, Michael A Taylor, Michael J Kuchta, Michael L Casner, Michael P Sheehan, Michael R Klapal, Michele L Obert, Michele Perry Williams, Miguel A Martinez, Miguel G Manzano, Mihaly S Ligmond, Milva E Melendez, Mohsen Rajabi Abhari, FDA, Moraima J Ramos Valle, Mra Davism, Mra Mcculloughj, Muralidhara B Gavini, PhD, Myriam M Sosa, Nancy G Schmidt, Neisa M Alonso, Nicholas L Paulin, Nicole A Lloyd, Noreen Muniz, Nutan Mytle, Pablo Feliciano, Pankaj H Amin, Patrick C Klotzbuecher, Paul A Bonneau, Paul L Bellamy, Paul Mouris, Pete Amin (Pankaj), Peter E Baker, Peter R Lenahan, Rafael E Arroyo, Rafael Nevarez, Rafael Nevarez Nieves, Ramon A Hernandez, Raymond T Oji, Rebecca Parrilla, Rebecca Rodriguez, Richard L Rutherford, Robert D Tollefsen, Robert J Doyle, Robert M Tillman, Roger F Zabinski, Roy R Rinc, Russell J Glapion, Sam H Haidar, PhD, Samina S Khan, Sandra A Hughes, Sarah A Hassas, Sharon K Thoma, PharmD, Simone E Pitts, Sixto M Mercado Rios, Sonia M Monges, Sony Mathews, Stephen D Eich, Stephen J Koniers, Steven B Barber, Steven C Madzo, Susant Hadman, Tajah L Blackburn, Terri L Dodds, Theressa B Smith, Thomas J Arista, Tiara M Brown, Tiffani D Wilson, Torrance J Slayton, Toyin B Oladimeji, Tracey L Harris, Truong Xuan Nguyen (Andy), Victoria A Wagoner, Vilmary Negron Rodriguez, Viviana Matta, Vlada Matusovsky, Walden H Lee, Wanda J Torres, Yong Hu, Yumi J Hiramine, Zachary A Bogorad, Zhongren Wu, Zuleika A Pineiro Vargas

Dr. Carmelo Rosa's Documents

Publish Date Document Type Title
May, 2000 EIR Patheon Puerto Rico, Inc. - EIR, 2000-05-01
September, 2003 FDA 483 Response Biosint S.p.A - Form 483R, 2003-11-22
December, 2003 FDA 483 Smithkline Beecham (Cork) Inc. - Form 483, 2003-12-02
July, 2002 EIR Dipharma Francis S.r.l. - EIR, 2002-07-11
July, 2001 EIR Smithkline Beecham (Cork) Inc. - EIR, 2001-07-06
May, 2006 FDA 483 MSD International GmbH (Puerto Rico Branch) LLC - Form 483, 2006-05-05
November, 2014 FDA 483 DR. REDDY'S LABORATORIES LIMITED - Form 483, 2014-11-21
July, 2001 FDA 483 Recordati Industria Chimica E. Farmaceutica S.P.A. - Form 483, 2001-07-26
July, 2007 FDA 483 Response Daiichi Sankyo Co.,Ltd. - Form 483R, 2007-08-22
October, 2003 FDA 483 Response Siegfried El Masnou, S.A. - Form 483R, 2003-10-17
July, 2001 FDA 483 Response Recordati Industria Chimica E Farmaceutica SpA - Form 483R, 2001-09-26
July, 2007 EIR Daiichi Sankyo Co.,Ltd. - EIR, 2007-07-26
July, 2001 EIR Recordati Industria Chimica E Farmaceutica SpA - EIR, 2001-07-26
October, 2003 EIR Siegfried El Masnou, S.A. - EIR, 2004-01-06
September, 2003 FDA 483 Sigma-Tau SPA - Form 483, 2003-09-19
May, 2000 FDA 483 Patheon Puerto Rico, Inc. - Form 483, 2000-05-01
September, 2003 EIR Biosint S.p.A - EIR, 2003-12-19
December, 2001 EIR Pfizer Pharmaceuticals LLC-Piperacillin - EIR, 2001-12-21
October, 2003 FDA 483 AlconCusi, SA - Form 483, 2003-10-02
July, 2001 FDA 483 SB Pharmco Puerto Rico Inc. / SmithKline Beecham Pharmaceuticals Co. - Form 483, 2001-07-06
June, 2001 FDA 483 Schering-Plough Products LLC - Form 483, 2001-06-13
September, 2003 FDA 483 Biosint S.p.A - Form 483, 2003-09-25
July, 2007 FDA 483 Daiichi Sankyo Co.,Ltd. - Form 483, 2007-07-26

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more